P

Pierrel SpA
MIL:PRL

Watchlist Manager
Pierrel SpA
MIL:PRL
Watchlist
Price: 1.745 EUR
Market Cap: 95.9m EUR
Have any thoughts about
Pierrel SpA?
Write Note
PRL
/
Cash Flow Statement
/
Other

Pierrel SpA
Other

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Pierrel SpA
Other Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other CAGR 3Y CAGR 5Y CAGR 10Y
P
Pierrel SpA
MIL:PRL
Other
-€278.2k
CAGR 3-Years
2%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Newron Pharmaceuticals SpA
SIX:NWRN
Other
-€170k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Recordati Industria Chimica e Farmaceutica SpA
MIL:REC
Other
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Friulchem SpA
MIL:FCM
Other
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Shedir Pharma Srl Unipersonale
MIL:SHE
Other
-€313k
CAGR 3-Years
-17%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Pierrel SpA
Glance View

Market Cap
95.9m EUR
Industry
Pharmaceuticals

Pierrel SpA engages in the development, manufacturing, and marketing of medical therapies for the pharmaceutical, bio-pharmaceutical, and life science industries. The company is headquartered in Capua, Caserta. The company went IPO on 2006-05-23. The firm specializes in the pharmaceutical research, development and the manufacture of medicines. The company operates through three segments. The Contract Manufacturing segment covers research and development of various types of drugs, such as Tube vials, bottles, ampoules, drops, sprays, tablets and gels. The company manufactures the drugs in the production facility in Capua, which consists of warehouses, chemical and microbiological laboratories, offices and utilities buildings. The Pharma segment is active in the development, registration and licensing of new drugs and medical devices. The Tech-driven Contract Research & Development Organization segment provides research of existing drugs for the treatment of rare diseases, among others.

PRL Intrinsic Value
1.849 EUR
Undervaluation 6%
Intrinsic Value
Price
P
What is Intrinsic Value?

See Also

What is Pierrel SpA's Other?
Other
-278.2k EUR

Based on the financial report for Jun 30, 2023, Pierrel SpA's Other amounts to -278.2k EUR.

What is Pierrel SpA's Other growth rate?
Other CAGR 3Y
2%

Over the last year, the Other growth was 19%. The average annual Other growth rates for Pierrel SpA have been 2% over the past three years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 211,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.